Pancreatic Cancer Research

ResearcherShenzhen UniversityNo recent work listed

Hongyan Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5985-8533; OpenAlex author ID A5065673570. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 3 papers

Papers 4

  1. LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis. Co-author DOI 10.1016/j.tranon.2021.101088↗
  2. Corrigendum to " LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis" [Translational Oncology 14(7):101088]. Co-author DOI 10.1016/j.tranon.2021.101143↗
  3. M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics13091493↗
  4. Orphan nuclear receptor Nurr1 as a potential novel marker for progression in human pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/etm.2016.3968↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zixiang Zhang · 2 shared papers, 2021 · strength 0.32
  2. Yu Chen · 2 shared papers, 2021 · strength 0.32
  3. Yongmei Zhao · 1 shared paper, 2021 · strength 0.16
  4. Yi Zhang · 1 shared paper, 2021 · strength 0.16
  5. Yuan‐Lin Zheng · 1 shared paper, 2021 · strength 0.16
  6. Tianqing Liu · 1 shared paper, 2021 · strength 0.16
  7. Gong Chen · 1 shared paper, 2017 · strength 0.07
  8. Guoxiong Zhou · 1 shared paper, 2017 · strength 0.07
  9. Ji Li · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.